GC Corp.

ARTV

GC Corp. serves as 10 percent owner at Artiva Biotherapeutics, Inc. (ARTV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$16.50M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$16.50M

Companies Traded

ARTV

Active Period

May 2026

1 total trades

Most Recent

Buy ARTV

May 28, 2026 · $16.50M

GC Corp.'s Insider Trading at Artiva Biotherapeutics, Inc. (ARTV)

Buys

1 · $16.50M

Sells

0 · $0.00

Total Shares Bought

1,432,291

Total Shares Sold

ARTV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 28, 2026	Buy	1,432,291	$11.52	$16.50M	4,391,969

Related Insiders

Christopher Horan

officer: Chief Tech Operations Officer

ARTVSell · May 19, 2026

Subhashis Banerjee

officer: Chief Medical Officer

ARTVSell · May 19, 2026

Jennifer Bush

officer: COO, CLO, Compliance Officer

ARTVSell · May 19, 2026

Fred Aslan

President and CEO

ARTVSell · May 19, 2026

Heather Raymon

SVP, Research and Development

ARTVSell · May 19, 2026

RA CAPITAL MANAGEMENT, L.P.

director, 10 percent owner:

ARTVBuy · May 13, 2026

Neha Krishnamohan

Chief Financial Officer

ARTVSell · Nov 15, 2025

Explore More Insider Trading Data

ARTV Insider Trading Activity

View all insider trades at Artiva Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity